Epitalon
Also known as: Ala-Glu-Asp-Gly · Epithalon · Epitalone
A short synthetic tetrapeptide developed in the Khavinson bioregulator programme, studied for telomere maintenance, pineal regulation, and indirect cognitive effects via circadian and stress-resilience pathways.
- Category
- Neuroprotection
- Half-life
- Short plasma half-life; gene-expression effects persist beyond clearance
- Formula
- C₁₄H₂₂N₄O₉
- Weight
- 390.35 g/mol
- Sequence
- Ala-Glu-Asp-Gly
Section 1
Overview
Epitalon is a synthetic four-amino-acid peptide developed in the same St. Petersburg Institute of Bioregulation and Gerontology programme that produced Pinealon, Cerluten, and Thymalin. The conceptual heritage is Vladimir Khavinson's hypothesis that very short peptides can pass through the cell and nuclear membranes and act as direct gene-expression regulators by binding specific DNA motifs.
The molecule is positioned in the Khavinson framework as a pineal-targeted bioregulator. Its most-cited research findings concern modulation of melatonin rhythms, induction of telomerase activity in cultured cells, and extension of average and maximum lifespan in rodent studies. The cognitive relevance — the reason it appears on a nootropic-peptide reference — is indirect: circadian regulation and stress-resilience modulation feed back into next-day cognitive performance, and ageing-related cognitive decline is one of the endpoints the broader programme targets.
Outside the Khavinson group and collaborators, independent replication of the most distinctive claims — particularly the direct DNA-binding mechanism — has been limited. The phenotypic effects on telomerase activity in cell culture are well-documented; the molecular details of how a tetrapeptide reaches and binds chromatin are more contested.
Section 2
Discovery & History
- Synthesised in the 1990s at the St. Petersburg Institute of Bioregulation and Gerontology under the direction of Vladimir Khavinson, as the synthetic equivalent of pineal-gland peptide extracts that the institute had been studying since the 1980s.
- Subject to a substantial body of Russian peer-reviewed work covering telomerase induction, melatonin-rhythm restoration, retinal-protection effects, and gerontoprotective outcomes in rodent models.
- Studied in human research primarily in Russia in elderly populations, with reports of improved sleep architecture, immune-function markers, and subjective wellbeing on cyclical administration protocols.
- Remains a research chemical in all Western jurisdictions, including the United Kingdom.
Section 3
Mechanism of Action
- 1Proposed direct binding to specific DNA promoter sequences in pineal-relevant genes, modulating transcription of melatonin-synthesis enzymes and other circadian effectors — the central Khavinson-school mechanism.
- 2Induction of telomerase activity in cultured human somatic cells, extending replicative lifespan and producing the cellular signature most associated with Epitalon in Western secondary literature.
- 3Restoration of melatonin-rhythm amplitude in aged animal models with otherwise blunted circadian melatonin production.
- 4Antioxidant effects in retinal and CNS tissue, particularly under age-related oxidative stress.
- 5Indirect downstream cognitive effects through circadian regulation and stress-axis attenuation — the route by which a pineal-acting peptide reaches cognitive endpoints.
Section 4
Researched Benefits
Findings reported in the published preclinical and clinical literature. Effects in research contexts do not constitute claims of therapeutic benefit in humans.
- 1Reported telomerase induction and extension of replicative lifespan in cultured cells.
- 2Restoration of melatonin-rhythm amplitude in aged animal models.
- 3Improvements in subjective sleep quality and wellbeing in Russian elderly-population research.
- 4Antioxidant and retinal-protective effects in oxidative-stress models.
- 5Used as a research tool for studying pineal-gland regulation and circadian-cognition relationships.
- 6Part of the broader gerontoprotective programme alongside Pinealon and other Khavinson bioregulators.
Section 5
Theoretical Dosing & Protocols
| Route | Dosage | Frequency | Duration |
|---|---|---|---|
| Subcutaneous / intranasal (research) | Microgram-range doses in animal and clinical-research protocols | Typically once daily during a course | Cyclical protocols of 10–20 days, repeated periodically rather than continuous |
Note: No standardised Western clinical protocol exists. Russian research practice uses cycles rather than continuous administration.
Section 6
Administration Routes
- Subcutaneous injection — the primary route in animal research and Russian clinical practice.
- Intranasal administration is documented in some protocols.
- Oral administration is not viable; the peptide is degraded by gastrointestinal proteases.
Section 7
Safety Profile
Commonly reported
- · Generally well-tolerated in published animal and Russian clinical research at studied doses
- · Mild local irritation at the injection site occasionally reported
Rare / theoretical
- · Long-term safety data outside the Khavinson group is limited
- · The direct DNA-binding mechanism (if it occurs as proposed) raises theoretical concerns about off-target gene regulation that have not been comprehensively investigated
- · Telomerase induction is itself a process implicated in some oncogenic pathways; whether the magnitude produced by Epitalon administration carries meaningful tumour-risk implications is uncharacterised
Contraindications
- · Not authorised for human use in the UK/EU/US
- · Pregnancy and lactation — no data
- · Active or historic malignancy — theoretical contraindication via the telomerase mechanism
Section 8
UK & EU Regulatory Context
United Kingdom
Not licensed as a medicine in the United Kingdom. Research chemical only.
European Union
Not approved by the EMA. Used in research and traditional clinical practice in the Russian Federation as part of the bioregulator family.
Section 9
Clinical Studies Summary
Epitalon and telomerase activity in cultured human somatic cells
Khavinson-group publications reporting dose-dependent induction of telomerase activity in human fibroblast cultures, with corresponding extension of replicative capacity beyond the Hayflick limit.
Pineal peptide effects on melatonin rhythm in aged animals
Restoration of melatonin amplitude and circadian-rhythm regularity in aged rodent models receiving cyclical Epitalon administration versus age-matched controls.
Gerontoprotective effect of Epitalon in long-term rodent studies
Extension of average and maximum lifespan in mouse and rat populations receiving lifelong Epitalon administration versus controls; effect attributed to combined circadian, antioxidant, and telomerase-related mechanisms.
Section 10
Frequently Asked Questions
Section 11
Sourcing for Laboratory Research
Sourcing Epitalon for laboratory research
Researchers in the United Kingdom and elsewhere typically obtain Epitalon from specialist research-chemical suppliers. Purity, third-party testing, and supplier transparency are the principal differentiators worth evaluating before placing an order. The two suppliers below are commonly referenced in UK research contexts.
Reminder: research peptides are sold strictly for in vitro and preclinical laboratory purposes. Importation or supply for human consumption is not permitted under UK medicines legislation.